Evidenzbasierte Nachsorge beim Mammakarzinom

Melden Sie sich bitte hier kostenlos und unverbindlich an, um den Inhalt vollständig einzusehen und weitere Services von www.medmedia.at zu nutzen.

Zur Anmeldung

AutorIn: Univ.-Prof. Dr. Michael Stierer

Facharzt für Chirurgie


1 Lu WL et al., Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis. Breast Cancer Res Treat 2009; 114 (3):403–412
2 GIVIO Investigators. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. JAMA 1994; 271 (20):1587–1592
3 Palli D et al., Intensive vs clinical follow-up after treatment of primary breast cancer: 10-year update of a randomized trial. National Research Council Project on Breast Cancer Follow-up. JAMA 1999; 281 (17):1586
4 Kokko R et al., Follow-up cost of breast cancer patients with localized disease after primary Treatment: a randomized trial. Breast Cancer Res Treat 2005; 93 (3):255–260
5 Rojas MP et al., Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev 2005; 2005 (1):CD001768
6 Morrow M et al., MRI for breast cancer screening, diagnosis and treatment. Lancet 2011; 378:1804–1811
7 Thomas DB et al., Randomized trial of breast self-examination in Shanghai: Final results. J Natl Cancer Inst 2002; 94:1445–1457
8 Singer CF et al., Leitlinie zur Prävention und Früherkennung von Brust- und Eierstockkrebs bei Hochrisikopatientinnen, insbesondere bei Frauen aus HBOC (Hereditary Breast and Ovarian Cancer) Familien. Wien Klin Wochenschr 2012; 124:334–339
9 Davies NJ et al., The role of diet and physical activity in breast, colorectal and prostate cancer Survivorship: a review of the literature. Br J Cancer 2011; 105 Suppl 1:S52–73
10 Nraula S et al., Bodysize and breast cancer prognosis in relation to hormonreceptor and menopausal status: a meta-analysis. Breast Cancer Res Treat 2012; 134:769–781
11 Khatcheressian JL et al., Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guidline Update. JCO 2013; 31 (7):961–965
12 Chua TC et al., Hepatic resection for metastatic breast cancer: A systematic review Eur J Cancer 2011; 47:2282–2286
13 Pagani O et al., International Guidelines for Management of Metastatic Breast Cancer: Can Metastatic Breast Cancer Be Cured: J Natl Cancer Inst 2010; 102:456–463
14 Salama JK et al., The Role of surgery and ablative radiotherapy in oligometastatic breast cancer. Semin Oncol. 2014; 41 (6):790–797
15 Empfehlungen der Österreichischen Gesellschaft für Senologie zur Nachsorge nach Mammakarzinom. www.senologie.at
16 Gnant M et al., Vortrag, gehalten am gemeinsamen Kongress der Österreichischen und Schweizer Gesellschaft für Senologie Lugano 2000
17 Nicolini A et al., „Tumor marker guided“ salvage treatment prolongs survival of breast cancer patients: final report of a 7-year study. Biomed Pharmacother 2003; 57 (10):452–459

SO 05|2014

Herausgeber: Univ.-Prof. Dr. Christoph Zielinski, Univ.-Prof. Dr. Markus Raderer
Publikationsdatum: 2014-12-31